Bridgewater Associates’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,387
Closed -$328K 841
2022
Q4
$328K Buy
+9,387
New +$328K ﹤0.01% 763
2022
Q2
Sell
-4,907
Closed -$357K 1045
2022
Q1
$357K Buy
+4,907
New +$357K ﹤0.01% 923